Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 76535-71-2
2. 77590-92-2
3. J4am5d708g
4. 37 162 R.p.
5. 37-162-rp
6. 37 162 R.p
7. Suproclona
8. Suproclonum
9. Suproclone [usan:inn]
10. Einecs 278-486-0
11. Unii-j4am5d708g
12. Rp 37162
13. Suproclone [inn]
14. Suproclone (usan/inn)
15. Suproclone [usan]
16. Schembl113028
17. Chembl2105531
18. Dtxsid00868445
19. Zinc01481925
20. (+-)-6-(7-chlor-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-7-oxo-5h-1,4-dithiixino(2,3-c)pyrrol-5-yl 4-propionyl-1-piperazincarboxylat
21. 37162-rp
22. 4-propinyl-1-piperazincarbonsaeure, Ester Mit (+-)-6-(7-chlor-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-7-hydroxy-5h-4-dithiino(2,3-c)pyrrol-5-on
23. 6-(7-chloro-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-7-oxo-5h-1,4-dithiino(2,3-c)pyrrol-5-yl 4-propionylpiperazine-1-carboxylate
24. Rp-37162
25. D05975
26. Q7645151
27. 1-piperazinecarboxylic Acid, 4-(1-oxopropyl)-, 6-(7-chloro-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-7-oxo-5h-1,4-dithiino(2,3-c)pyrrol-5-yl Ester, (+-)-
28. 4-(1-oxopropyl)-1-piperazinecarboxylic Acid [6-(7-chloro-1,8-naphtyridin-2-yl)-2,3,6,7-tetrahydro-7-oxo-5h-1,4-dithiino[2,3-c]pyrrol]-5-yl Ester
29. 4-propionyl-1-piperazinecarboxylic Acid, Ester With (+-)-6-(7-chloro-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-7-hydroxy-5h-p-dithiino(2,3-c)pyrrol-5-one
30. 6-(7-chloro-1,8-naphthyridin-2-yl)-7-oxo-2,3,6,7-tetrahydro-5h-[1,4]dithiino[2,3-c]pyrrol-5-yl 4-propanoylpiperazine-1-carboxylate
| Molecular Weight | 520.0 g/mol |
|---|---|
| Molecular Formula | C22H22ClN5O4S2 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 519.0801742 g/mol |
| Monoisotopic Mass | 519.0801742 g/mol |
| Topological Polar Surface Area | 147 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 868 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Suproclone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Suproclone, including repackagers and relabelers. The FDA regulates Suproclone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Suproclone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Suproclone supplier is an individual or a company that provides Suproclone active pharmaceutical ingredient (API) or Suproclone finished formulations upon request. The Suproclone suppliers may include Suproclone API manufacturers, exporters, distributors and traders.
click here to find a list of Suproclone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Suproclone DMF (Drug Master File) is a document detailing the whole manufacturing process of Suproclone active pharmaceutical ingredient (API) in detail. Different forms of Suproclone DMFs exist exist since differing nations have different regulations, such as Suproclone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Suproclone DMF submitted to regulatory agencies in the US is known as a USDMF. Suproclone USDMF includes data on Suproclone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Suproclone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Suproclone suppliers with USDMF on PharmaCompass.
Suproclone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Suproclone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Suproclone GMP manufacturer or Suproclone GMP API supplier for your needs.
A Suproclone CoA (Certificate of Analysis) is a formal document that attests to Suproclone's compliance with Suproclone specifications and serves as a tool for batch-level quality control.
Suproclone CoA mostly includes findings from lab analyses of a specific batch. For each Suproclone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Suproclone may be tested according to a variety of international standards, such as European Pharmacopoeia (Suproclone EP), Suproclone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Suproclone USP).
LOOKING FOR A SUPPLIER?
